Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$124K Hold
2,368
0.05% 162
2026
Q1
$131K Sell
2,368
-495
-17% -$26.8K 0.06% 155
2025
Q4
$140K Buy
+2,863
New +$134K 0.06% 151
2025
Q2
$98.1K Hold
2,641
0.05% 176
2025
Q1
$102K Buy
2,641
+126
+5% +$4.61K 0.05% 174
2024
Q4
$85K Sell
2,515
-168
-6% -$6.05K 0.04% 190
2024
Q3
$110K Hold
2,683
0.05% 175
2024
Q2
$103K Sell
2,683
-245
-8% -$10.3K 0.05% 176
2024
Q1
$125K Hold
2,928
0.07% 160
2023
Q4
$109K Buy
2,928
+398
+16% +$14.3K 0.06% 168
2023
Q3
$91.7K Hold
2,530
0.06% 175
2023
Q2
$90K Buy
+2,530
New +$90.8K 0.05% 174

Other funds holding GSK

Union Savings Bank's GSK Position: Q2 2026 in Review

Union Savings Bank held its GSK (GSK) position steady in Q2 2026 at 2,368 shares worth $124K. The position accounts for 0.05% of the portfolio, ranked #162.

Union Savings Bank first reported a position in GSK in Q2 2023 and has held it in 12 quarters since. The position peaked at $140K in Q4 2025. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Union Savings Bank held 2,368 shares of GSK worth $124K as of Q2 2026.
  • Union Savings Bank left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.05% of Union Savings Bank's portfolio in Q2 2026, its #162 holding.
  • Union Savings Bank first reported a position in GSK in Q2 2023 and has held it in 12 quarters since.
  • Union Savings Bank's GSK position peaked at $140K in Q4 2025.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Union Savings Bank's 13F filing for Q2 2026, filed 23 Jul 2026.